M 17055

Drug Profile

M 17055

Alternative Names: Alilusem; MD 31

Latest Information Update: 13 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mochida Pharmaceutical
  • Class
  • Mechanism of Action Diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Heart failure; Hypertension; Oedema

Most Recent Events

  • 07 Sep 1998 No-Development-Reported for Heart failure in Japan (Unknown route)
  • 07 Sep 1998 No-Development-Reported for Hypertension in Japan (Unknown route)
  • 06 Mar 1998 Phase-I clinical trials for Oedema in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top